These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30817436)

  • 1. A deeper look at pain variability and its relationship with the placebo response: results from a randomized, double-blind, placebo-controlled clinical trial of naproxen in osteoarthritis of the knee.
    Treister R; Honigman L; Lawal OD; Lanier RK; Katz NP
    Pain; 2019 Jul; 160(7):1522-1528. PubMed ID: 30817436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staircase-evoked Pain May be More Sensitive Than Traditional Pain Assessments in Discriminating Analgesic Effects: A Randomized, Placebo-controlled Trial of Naproxen in Patients With Osteoarthritis of the Knee.
    Treister R; Suzan E; Lawal OD; Katz NP
    Clin J Pain; 2019 Jan; 35(1):50-55. PubMed ID: 30222614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib.
    Holt RJ; Fort JG; Grahn AY; Kent JD; Bello AE
    Phys Sportsmed; 2015 Jul; 43(3):200-12. PubMed ID: 26313454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the analgesic efficacy and safety of nonprescription doses of naproxen sodium and Ibuprofen in the treatment of osteoarthritis of the knee.
    Schiff M; Minic M
    J Rheumatol; 2004 Jul; 31(7):1373-83. PubMed ID: 15229960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of naproxcinod in the treatment of patients with osteoarthritis of the knee: a 13-week prospective, randomized, multicenter study.
    Schnitzer TJ; Kivitz A; Frayssinet H; Duquesroix B
    Osteoarthritis Cartilage; 2010 May; 18(5):629-39. PubMed ID: 20202489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis.
    Mayorga AJ; Flores CM; Trudeau JJ; Moyer JA; Shalayda K; Dale M; Frustaci ME; Katz N; Manitpisitkul P; Treister R; Ratcliffe S; Romano G
    Scand J Pain; 2017 Oct; 17():134-143. PubMed ID: 28850367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropomyosin-related kinase A (TrkA) inhibition for the treatment of painful knee osteoarthritis: results from a randomized controlled phase 2a trial.
    Watt FE; Blauwet MB; Fakhoury A; Jacobs H; Smulders R; Lane NE
    Osteoarthritis Cartilage; 2019 Nov; 27(11):1590-1598. PubMed ID: 31356878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A walking model to assess the onset of analgesia in osteoarthritis knee pain.
    Peeva E; Beals CR; Bolognese JA; Kivitz AJ; Taber L; Harman A; Smugar SS; Moskowitz RW
    Osteoarthritis Cartilage; 2010 May; 18(5):646-53. PubMed ID: 20175977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
    Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
    Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater reduction of knee than hip pain in osteoarthritis treated with naproxen, as evaluated by WOMAC and SF-36.
    Svensson O; Malmenäs M; Fajutrao L; Roos EM; Lohmander LS
    Ann Rheum Dis; 2006 Jun; 65(6):781-4. PubMed ID: 16269428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responsiveness of the OARSI-OMERACT osteoarthritis pain and function measures.
    Bond M; Davis A; Lohmander S; Hawker G
    Osteoarthritis Cartilage; 2012 Jun; 20(6):541-7. PubMed ID: 22425883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee.
    Huggins JP; Smart TS; Langman S; Taylor L; Young T
    Pain; 2012 Sep; 153(9):1837-1846. PubMed ID: 22727500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized placebo-controlled trial comparing efficacy and safety of valdecoxib with naproxen in patients with osteoarthritis.
    Kivitz A; Eisen G; Zhao WW; Bevirt T; Recker DP
    J Fam Pract; 2002 Jun; 51(6):530-7. PubMed ID: 12100776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: a short-term randomized, double-blind pilot study.
    Levy RM; Saikovsky R; Shmidt E; Khokhlov A; Burnett BP
    Nutr Res; 2009 May; 29(5):298-304. PubMed ID: 19555810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Responsiveness of the Intermittent and Constant Osteoarthritis Pain (ICOAP) scale in a trial of duloxetine for treatment of osteoarthritis knee pain.
    Risser RC; Hochberg MC; Gaynor PJ; D'Souza DN; Frakes EP
    Osteoarthritis Cartilage; 2013 May; 21(5):691-4. PubMed ID: 23485934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naproxen effects on brain response to painful pressure stimulation in patients with knee osteoarthritis: a double-blind, randomized, placebo-controlled, single-dose study.
    Giménez M; Pujol J; Ali Z; López-Solà M; Contreras-Rodríguez O; Deus J; Ortiz H; Soriano-Mas C; Llorente-Onaindia J; Monfort J
    J Rheumatol; 2014 Nov; 41(11):2240-8. PubMed ID: 25274897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of flavocoxid compared with naproxen in subjects with osteoarthritis of the knee- a subset analysis.
    Levy R; Khokhlov A; Kopenkin S; Bart B; Ermolova T; Kantemirova R; Mazurov V; Bell M; Caldron P; Pillai L; Burnett B
    Adv Ther; 2010 Dec; 27(12):953-62. PubMed ID: 20972845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
    Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
    Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
    Clegg DO; Reda DJ; Harris CL; Klein MA; O'Dell JR; Hooper MM; Bradley JD; Bingham CO; Weisman MH; Jackson CG; Lane NE; Cush JJ; Moreland LW; Schumacher HR; Oddis CV; Wolfe F; Molitor JA; Yocum DE; Schnitzer TJ; Furst DE; Sawitzke AD; Shi H; Brandt KD; Moskowitz RW; Williams HJ
    N Engl J Med; 2006 Feb; 354(8):795-808. PubMed ID: 16495392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis.
    Lohmander LS; McKeith D; Svensson O; Malmenäs M; Bolin L; Kalla A; Genti G; Szechinski J; Ramos-Remus C;
    Ann Rheum Dis; 2005 Mar; 64(3):449-56. PubMed ID: 15345500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.